REPL

Replimune Group, Inc.NASDAQHealthcare

$8.41+10.51%ClosedMarket Cap: $694.4M

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-02-05	Piper Sandler	—	Overweight	—
2026-02-04	Wedbush	—	Outperform	—
2025-11-03	BMO Capital	—	Market Perform	—
2025-10-27	HC Wainwright & Co.	—	Buy	—
2025-10-20	Leerink Partners	—	Outperform	—
2025-10-20	Wedbush	—	Outperform	—
2025-10-20	JP Morgan	—	Neutral	—
2025-09-19	JP Morgan	—	Underweight	—
2025-09-08	HC Wainwright & Co.	—	Neutral	—
2025-07-30	Cantor Fitzgerald	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Wed Mar 31	$-2.12	$59.2M	4
Fri Mar 31	$-1.30	$153.0M	4
Sat Mar 31	$-0.01	$216.4M	4
Sun Mar 31	$0.80	$315.7M	2

REPL | Replimune Group, Inc. Analyst Ratings & Price Target - InvestLog